NANO-X IMAGING LTD NNOX 深 沪
交易中 04-01 10:43:54 美东时间
2.47
+0.200
+8.81%
华盛通- 最 高2.48
- 今 开2.34
- 成交量 64.88万股
- 最 低 2.30
- 昨 收 2.27
- 总市值 1.72亿
- 52周最高 5.86
- 市盈率 静 --
- 换手率 0.93%
- 52周最低 2.11
- 委 比 -28.43%
- 总股本 6959.02万
- 历史最高 94.81
- 量 比 5.02
- 振 幅 7.93%
- 历史最低 2.11
- 每 手 1
- 风险率 1.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nano-x Imaging Subsidiary, Nanox Impact, Signs Distribution Agreement with Elite Surgical Technologies For Nanox.ARC Deployment
Distribution agreement to enhance channel partner expansion across five U.S. statesThe collaboration is expected to support adoption of advanced 3D imaging within orthopedic practices and surgical settings that
今天 20:06
Billion-Dollar Opportunity Emerges for RF Sensing Technologies in Offshore Exploration
Demand surges as operators prioritize safety, uptime, and data-driven operations NEW YORK, March 24, 2026 /PRNewswire/ -- Market News Updates News Commentary - RF sensing technologies are be...
03-24 21:00
Nano-X Imaging U.S. Subsidiary Inks New Distribution Deal With Imperial Imaging Technology Over Commercial Launch Of Nanox.ARC
Nano-X Imaging Ltd. (NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that its US-based subsidiary, Nanox Impact Inc. has signed a new distribution agreement with Imperial Imaging
03-03 21:02
Nanox to Showcase Nanox.ARC Live in Europe for First Time and Present New AI Capabilities at ECR 2026
Nanox将在2026年欧洲放射学大会上首次现场展示其Nanox.ARC数字体层摄影系统，并展示新的AI解决方案。Nanox.ARC具有成本低、辐射剂量低和占地面积小的优势，适用于各种医疗环境。大会期间，Nogah Shabshin博士将探讨数字体层摄影在肺癌筛查中的潜力，Orit Wimpfheimer博士将展示AI在多种疾病检测中的应用。海报展示将突出从ADOPT研究中获得的新临床数据，展示AI在椎体骨折识别上的影响。会议时间为2026年3月4日至8日，地点为奥地利维也纳，提供现场演示和讨论机会。
02-17 13:10
美股大行评级 | 泰瑞达、Lumentum、哈贝尔、Enphase能源、西部数据获多家机构上调目标价；PayPal 、恩智浦、墨式烧烤遭多家机构下调目标价
今日重点评级关注：韦德布什：维持Replimune Group"跑赢大市"评级，目标价从18美元升至19美元；巴克莱：维持CytomX Therapeutics"超配"评级，目标价从8美元升至10美元
02-05 11:28
D. Boral Capital Maintains Buy on Nano X Imaging, Lowers Price Target to $5
D. Boral Capital analyst Jason Kolbert maintains Nano X Imaging (NASDAQ:NNOX) with a Buy and lowers the price target from $8 to $5.
02-04 20:44
Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems
FDA approves Nanox's TAP2D capability, enhancing digital tomosynthesis systems by providing 2D views alongside 3D scans, reducing radiation and costs while improving diagnostic accuracy. This marks a key step toward Nanox's aim of making its systems standalone primary imaging solutions in the U.S., as they are in Europe. The update emphasizes Nanox's commitment to innovation and accessibility, building on its AI-driven, cloud-based platform to re...
02-03 13:15
AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, Jan. 27, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary – The global medical imaging market hit a massive $45.5 billion...
01-27 23:14
NANO-X IMAGING Partners With Althea France To Distribute CE-Marked Nanox.ARC Imaging System Across French Healthcare Sector
Althea France, part of one of Europe's largest independent medical technology services providers, to distribute CE-marked Nanox.ARC system across French healthcare sectorPartnership represents Nanox's fourth
2025-11-25 21:13
NANO-X IMAGING launches $15M stock offering
NANO-X IMAGING (NNOX) has announced a stock offering to raise gross proceeds of approximately $15 million. The medical imaging technology company entered into a securities purchase agreement with a si...
2025-11-24 17:17
